Stella Pharma Corporation (TYO:4888)

Stella Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 24, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	13,375	9,087	11,485	17,281	-	-
Market Cap Growth	105.37%	-20.88%	-33.54%	-	-	-
Enterprise Value	10,736	7,501	10,146	14,767	-	-
Last Close Price	393.00	291.00	387.00	603.00	-	-
PS Ratio	39.76	33.78	50.15	172.82	-	-
PB Ratio	4.50	3.82	4.17	5.61	-	-
P/TBV Ratio	6.25	3.91	4.27	5.74	-	-
EV/Sales Ratio	33.24	27.88	44.31	147.68	-	-
Debt / Equity Ratio	0.27	0.39	0.40	0.41	6.14	2.28
Asset Turnover	0.07	0.07	0.05	0.03	0.09	-
Inventory Turnover	0.04	0.05	0.03	0.03	0.07	-
Quick Ratio	14.96	5.34	6.58	10.69	4.09	6.67
Current Ratio	20.67	7.98	9.01	13.56	5.67	7.82
Return on Equity (ROE)	-23.64%	-29.76%	-26.68%	-46.36%	-143.26%	-82.15%
Return on Assets (ROA)	-9.28%	-11.66%	-11.14%	-13.69%	-18.08%	-18.93%
Return on Capital (ROIC)	-11.24%	-13.28%	-12.32%	-15.50%	-21.79%	-21.55%
Earnings Yield	-4.99%	-8.40%	-6.77%	-4.44%	-	-
FCF Yield	-9.75%	-7.43%	-6.52%	-	-
Buyback Yield / Dilution	-7.01%	-7.27%	-2.83%	-40.17%	-28.43%	-20.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.